在中国南部的儿童中,为优化万科米辛的剂量方案,对人口的药理动力学分析
Xianhuan Shen1,2, Xuejuan Li3, Jieluan Lu1,2
1Shenzhen Baoan Women's and Children's Hospital, Jinan University, Shenzhen, China.
CPT: pharmacometrics & systems pharmacology
|April 30, 2024
概括
由于药理动力学变异性,儿童的万科米辛剂量需要个性化方案. 这项研究为中国南方儿科患者建立了最佳的万科米辛剂量策略,以提高治疗疗效.
科学领域:
- 药理学 药理学是指药理学的学科.
- 儿科医学 儿科医学
- 临床药房 临床药房
背景情况:
- 儿科患者的生理变化导致了旺科米辛药物动力学的显著变化.
- 这种变化可能导致无效或有毒的药物暴露,影响治疗结果.
- 对儿科患者来说,优化万科米辛剂量至关重要.
研究的目的:
- 在中国南方儿童中表征万科米辛的处置.
- 量化治疗疗效的目标暴露.
- 为了为这个人群建立最佳的万科米辛剂量方案.
主要方法:
- 对453名住院儿童进行回顾性人群药理动力学 (PPK) 分析.
- 使用NONMEM®软件开发一个单间PPK模型.
- 纳入体重和功能 (截止年龄为2年) 作为共变量.
主要成果:
- 该模型通过内部和外部验证证明了强大的预测性能.
- 在24小时内,曲线下的面积与最小抑制度比 (AUC024/MIC) ≥260预测的治疗疗效.
- 通过蒙特卡洛模拟推量身定制的,而不是平面的剂量方案.
结论:
- 较低的AUC024/MIC目标可能足以在儿童中获得临床有效性.
- 推的剂量方案是根据暴露与疗效的关系得出的.
- 需要进一步的前性研究来验证这些发现.
相关概念视频
Drug Dosage Regimen: Overview
3.5K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.5K
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
131
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
131
Analysis of Population Pharmacokinetic Data
252
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
252
Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation
482
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
On...
482
Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters
89
The noncompartmental approach is a widely used method in pharmacokinetics to assess drugs' behaviors in the body. It considers several factors, including clearance, bioavailability, and total volume of distribution.
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
89


